Pharmacy Times

JULY 22, 2025

Compounding this issue, many pharmacies face ongoing staffing shortages, which hinder efficient operations and compromise the ability to deliver quality patient care. Telepharmacy services: present status and future perspectives: a review. Overexpansion and staffing issues also play a role. Health Aff Sch. 2024;2(4):qxae035.

Pharmacy Technician

Pharmacy Times

JUNE 27, 2025

Patients often present with peripheral blood, bone marrow, and splenic involvement. 5 Phase 3 ECHO Trial: A New Frontline Option The approval was supported by data from the phase 3 ECHO trial (NCT02972840), presented at the 2024 European Hematology Association Hybrid Congress. There is currently no universal standard of care for MCL.

Pharmacy Technician

pharmaphorum

JUNE 12, 2025

These closures, compounded by the decline of independent pharmacies, create a critical gap in care. R&D Life Sciences Industry Report - Biologics and Generics The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.

Health and Personal Care Stores

Pharmacy Times

JUNE 24, 2025

In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO). The early response rates look excellent.

Pharmacy Technician

Pharmacy Times

JULY 25, 2025

These data present a concerning reality in pneumococcal vaccine coverage, one that may have been exacerbated during the COVID-19 pandemic. Public transit cuts during COVID-19 compound social vulnerability in 22 US cities. According to 2022 data from a National Health Interview Survey of US adults ages 18 and older, just 23.0%

Vaccines

Pharmacy Times

JUNE 12, 2025

The increasing use of herbal supplements among patients undergoing cancer treatment, particularly those on oral therapies, presents a significant and often unaddressed challenge in oncology care. Participants can present their work, exchange ideas, and connect with leaders in the field during these networking opportunities.

Pharmacy Technician

Pharmacy Times

JUNE 9, 2025

A retrospective study presented at the American Society of Health-System Pharmacists 2025 Pharmacy Futures meeting has revealed significant variability in asthma treatment regimens following initial diagnosis, with many patients not receiving care aligned with the Global Initiative for Asthma (GINA) recommendations. REFERENCES 1.

Pharmacy Technician

Pharmacy Times

JUNE 16, 2025

1 The findings were presented at the Revolutionizing Atopic Dermatitis (RAD) 2025 conference held in Nashville, Tennessee. Related Videos Related Content Advertisement June 16th 2025 FDA Approves Ustekinumab-Stba, Biosimilar to Stelara, for Pediatric Patients With PsO or PsA Gillian McGovern, Associate Editor June 3rd 2025 S2.

Pharmacy Technician

Pharmacy Times

JULY 12, 2025

Presented at: McKesson ideaShare 2025. Find an example of someone who’s doing it somewhere else, and I’m willing to bet they’ll take the time to sit down and help you figure out how to make it work in your state.” REFERENCES 1. Kinsey JD, Meredith A, Novak N, Howard M. Nashville, TN; July 11, 2025. News release.

Pharmacy Technician

Pharmacy Times

JUNE 25, 2025

Despite its proven efficacy, the conventional oral administration of lenalidomide presents challenges due to its short half-life and the high systemic exposure required to sustain therapeutic drug levels, which can lead to significant toxicities, particularly grade 3 or 4 hematologic adverse events (AEs).

Pharmacy Technician

Pharmacy Times

JUNE 13, 2025

During an earlier presentation, Klepser states that there are 150 US counties that do not have a pharmacy or pharmacist. Presented at: American Association of Pharmacy Technicians 2025 Annual Pharmacy Technician Convention. It is absolutely crucial to know how we might get to a point where this is actually a business model. Denver, CO.

Pharmacy Technician

Pharmacy Times

AUGUST 14, 2025

1-4 Image credit: Semi | stock.adobe.com Pharmacists need to remember a few clinical pearls when patients present with prescriptions for SGLT2 inhibitors. Again, SGLT2 inhibitors cause osmotic diuresis that usually presents as thirst, polyuria, lightheadedness, or fatigue. Clinical Pearl No.

Diabetes

Pharmacy Times

JULY 19, 2025

While the results of this study were presented at the American College of Cardiology meeting in 2023, the completed study results have yet to be published. The addition of beta blockers or other drug classes are indicated when BP goals are not achieved or if concomitant comorbidities are present. Presented at ACC/WCC 2023.

HIV Treatment and Prevention Agents

Pharmacy Times

AUGUST 14, 2025

The designation follows positive results from the ongoing BEACON phase 1/2 clinical trial (NCT05456880), which were presented at the 2025 European Hematology Association (EHA) Congress. The enrolled patients required a median of 1 mobilization cycle (range: 1–3 cycles).

Pharmacy Technician

Pharmacy Times

JUNE 12, 2025

The session, which was entitled “Decoding the Logic: An Overview of Biologics and Biosimilars,” described clinical applications and economic impacts associated with biologics and biosimilars over the last 10 to 15 years, as well as outlined what skills effectively contribute to their management and understanding.

Biosimilars

Pharmacy Times

JULY 4, 2025

The study's primary objective was to assess reversion rates to Humira, with 9% reverting after three months, while 91% remained on biosimilars or switched to alternatives. SHOW MORE Real-world data shows patients switching from Humira to biosimilars Hadlima and Hyrimoz achieve similar outcomes without hospitalization.

Biosimilars

Pharmacy Times

JUNE 11, 2025

Image Credit: © Chinnapong - stock.adobe.com At the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025, an encore presentation from the Pacific Coast Reproductive Society Annual Meeting will highlight findings from a retrospective analysis conducted by Walgreens Specialty Pharmacy.

Pharmacy Technician

Pharmacy Times

JUNE 17, 2025

SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. Participants can present their work, exchange ideas, and connect with leaders in the field during these networking opportunities. AON Pharmacy's interventions saved $1.9

Mail-Order Pharmacies

Pharmacy Times

JUNE 20, 2025

Pharmacy Times: What are some key sessions that will be presented at the upcoming 2025 ADA Scientific Sessions? Pharmacy Times: What role do you see pharmacists playing in the discussions and advancements presented at the event? Isaacs : I am so excited for the ADA Scientific Sessions. It is my favorite meeting of the entire year.

Diabetes

Pharmacy Times

JULY 22, 2025

When you are enjoyable to work with, reliable, organized, and do impactful work, your name often comes up in spaces where you’re not present, opening doors to new partnerships. Strong collaborations lead to opportunities. It’s a cycle of trust and shared success, and I’ve been fortunate to benefit from and contribute to it.

Pharmacy Technician

Pharmacy Times

JULY 22, 2025

Alixorexton presents as a hopeful, potentially paradigm-shifting treatment for this population. OX2Rs play a critical role in the maintenance of wakefulness in patients with NT1, which is characterized by the loss of orexin-producing neurons in cerebrospinal fluid.

Pharmacy Technician

Pharmacy Times

JUNE 20, 2025

Pharmacy Times : Can you share what you presented at the 2025 OPC meeting? My role is really about using my expertise with medications to support decision-making based on data, like abstracts presented at meetings like this one, to ensure patients receive the best possible treatment.

Pharmacy Technician

Pharmacy Times

AUGUST 2, 2025

Role of PCP Counseling for Observers Fasting may present risks to post-metabolic and bariatric surgery (MBS) patients. About the Author Amy C. Nieto is a 2026 PharmD Candidate at the University of Connecticut School of Pharmacy in Storrs, CT.

Diabetes

Pharmacy Times

JULY 23, 2025

Understanding and addressing these emotional barriers may present an opportunity to improve adherence and long-term engagement. For patients beginning treatment with immunology biologics or other specialty medications, the transition can be daunting, involving new routines, adverse effect concerns, and evolving perceptions of illness.

Specialty Pharmacies

Pharmacy Times

JUNE 23, 2025

Presented at: Hematology/Oncology Pharmacy Association 2025 Annual Conference; April 9-12, 2025; Portland, OR. If the request doesn’t come in, all 505(b)(2) drugs will be considered nontherapeutically equivalent and therefore get their own J-code. That’s the system we are headed into very rapidly.” REFERENCE Soefje SA.

Pharmacy Technician

Pharmacy Times

JUNE 26, 2025

The findings, published in The New England Journal of Medicine and presented at the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois, demonstrated that 10 of the 12 treated individuals no longer needed insulin treatment in a 1-year follow-up.

Diabetes

Pharmacy Times

AUGUST 14, 2025

4 There are different types of SPS based on clinical and physical presentation. Magnetic resonance imaging of the brain and spinal cord is also commonly performed to exclude structural or demyelinating diseases that could present similar symptoms. Treatment options often require trial, monitoring, and adjustment as needed.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 31, 2025

If a patient presents with pneumococcal disease, conducting medication reconciliation and ensuring all medications a patient is taking are not negatively contributing to their disease is critical.

Pharmacy Technician

Pharmacy Times

JUNE 9, 2025

Abuse Deterrent Pharma, LLC (ADP), has licensed the LIMITX technology from Acura Pharmaceuticals for a number of pharmaceutical compounds. It has been used frequently for manufacturing poorly soluble compounds. trillion economic impact in 2020. trillion economic impact in 2020.

Pharmacy Technician

Pharmacy Times

JULY 2, 2025

Ototoxicity, presenting as tinnitus, hearing loss, dizziness, or vertigo, could occur and can be reversible or permanent. The injection is available at room temperature and does not require compounding, thawing, activation, or dilution. 1 The injection is available in 7 different presentations that range from 0.5

Pharmacy Technician

Pharmacy Times

AUGUST 6, 2025

These data were presented at the 2025 American Academy of Neurology (AAN) Annual Meeting. 2,3 According to the data presented at the AAN session, fremanezumab was observed to significantly reduce monthly migraine days compared with placebo (–2.5 vs –1.4; P =.0210).

Pharmacy Technician

Pharmacy Times

JULY 23, 2025

1 Patient Selection and Management for GLP-1 Therapy With so many GLP-1 options available, pharmacists are essential in counseling patients on available therapies based on their disease presentation, designating proper titrations and dosing schedules, and monitoring potential adverse effects. Banting & Best: the discovery of insulin.

Diabetes

Pharmacy Times

JULY 9, 2025

1 These data, which were presented at the 2025 American Society of Clinical Oncology Annual Meeting, provide more guidance for clinical oncology pharmacists and oncologists when treating patients with a higher risk of serious infections. At 12 months, 4.8% of patients experienced serious infections, with the incidence increasing to 5.6%

Pharmacy Technician

Pharmacy Times

AUGUST 12, 2025

Eligible participants were adults (≥ 18 years) with histologically confirmed R/R DLBCL who had received 1 or more prior systemic therapy and were deemed ineligible for autologous stem cell transplantation. month follow-up was 13.5 (7.9-18.5) vs not evaluable (19.2-not not evaluable) for R-GemOx vs glofit-GemOx (HR, 0.59; P =.011),

Pharmacy Technician

Pharmacy Times

JUNE 22, 2025

Buse noted that further details would be presented at ADA. 1 Stroke Outcomes Inzucchi presented the stroke outcomes assessed in SOUL, noting that diabetes doubles stroke risk, especially in the presence of elevated A1C. While oral semaglutide reduced MACE by 14%, the reduction in stroke alone was not statistically significant.

Pharmacy Technician

Pharmacy Times

AUGUST 7, 2025

While RSV symptoms typically present as mild and cold-like, some individuals could develop more severe symptoms like pneumonia. Annually, an estimated 110,000 to 180,000 individuals 50 years and older are hospitalized due to RSV in the US.

Long-Term Care Facilities

Pharmacy Times

JULY 22, 2025

The Intersection of AI and Pharmacogenetics The integration of AI technologies with pharmacogenetics presents powerful opportunities for enhancing medication therapy management. Demonstrating improved outcomes and cost-effectiveness helps ensure payer support and broadens access to precision therapies.

Pharmacy Technician